Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-039-7 | CAS number: 13114-72-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 03.02.-19.02.2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
Test material
- Reference substance name:
- 3-methyl-1,1-diphenylurea
- EC Number:
- 236-039-7
- EC Name:
- 3-methyl-1,1-diphenylurea
- Cas Number:
- 13114-72-2
- Molecular formula:
- C14H14N2O
- IUPAC Name:
- 3-methyl-1,1-diphenylurea
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Name of test material: 3-Methyl-1,1-diphenylurea- Physical state: white solid powder- Composition of test material, percentage of components: main component: 3-Methyl-1,1-diphenylurea CAS:13114-72-2 >98% (w/w) impurities: unlisted additives: unlisted-Molecular formula: C14H14N2O-Molecular weight: 226,27-Batch No.: 14015- Expiration date of the lot/batch: 11/2019- Stability under test conditions: stable- Storage condition of test material: in closed container, in dry room at room temperature (at laboratory conditions)
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS- Source: breeding farm VELAZ s.r.o., Únětice, Czech Republic, RČH CZ 21760152- Age at study initiation: 6-7 weeks- Weight at study initiation: 112,76 g-136,62 g- Fasting period before study: 20 hours before study- Housing: animal room with monitoring conditions – 3 animals of one sex in one plastic breeding cage Velaz T4, sterilized shavings of soft wood- Diet: complete pelleted standard diet for experimental animals, ad libitum- Water: drinking water, ad libitum- Acclimation period: 6 daysENVIRONMENTAL CONDITIONS- Temperature (°C): 22 ± 3°C, permanently monitored- Humidity (%): 30 – 70 %, permanently monitored- Photoperiod (hrs dark / hrs light): light period 12-hour light/12 hour dark Body weight: before application, 8th day and before euthanasia of animalsMortality: dailyClinical examination: dailyPathological examination: 15th day
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- olive oil
- Details on oral exposure:
- VEHICLE- Olive oil (pharmaceutical quality)- Batch No.: 5523502- Expiration: 09/2015- Manufacturer: Dr.Kulich Pharma s.r.o., Piletická 178/61, 500 03 Hradec KrálovéDOSAGE PREPARATION- test substance was weighted and mixed in vehicle (olive oil)- single volume of administered suspension was 1ml/100g of animal body weight.CLASS METHOD (if applicable)- Rationale for the selection of the starting dose: On the basis of information about none toxic effect the starting dose of 2000 mg/kg was selected.
- Doses:
- 2000, 300 mg/kg
- No. of animals per sex per dose:
- 3 animals per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days - Frequency of weighing: before application, at the 8th day of study and at the 15th day, before euthanasia of animals.- Necropsy of survivors performed: yes- Other examinations performed: clinical signs, body weight,Nutritious status, body surface, body foramina, thoracic, abdominal and cranial cavity
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 300 - < 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- yesThe test substance administered at the dose of 2000 mg/kg caused death of two females.Remaining one female had to be humanely sacrificed for moribund status in the morning 2nd day of the study.See tables No.:3 and 4
- Clinical signs:
- At the dose 2000 mg/kg: all three femalespiloerection, gibbous posture, decreased reaction to stimuli, tachypnoea, the lateral posture, ataxia (pulling body and pelvic legs), red discharge fromnostrils and salivation, the cachexy, fur stained by urine, cyanosis of skin and mucous membrane, haemorrhagic discharge from nostrils and eye, the dilatation and flatulence of stomach.At dose 300 mg/kg: all six femalesno clinical signs of intoxicationSee tables No.:3 and 4
- Body weight:
- At dose 2000 mg/kg: all animals lost weigtat dose 300 mg/kg: all animals gained weightSee tables No.: 1 and 2
- Gross pathology:
- At dose 2000 mg/kg: all three femalesBody surface: cachexy, fur stained by urine and cyanosis of skin and mucous membrane, heamorrhagic discharge (nostrils, eye)Stomach - dilatation and flutulance. At dose 300 mg/kg: all six femalesno macroscopic changes
Any other information on results incl. tables
Table No. 1: Individual body weight (g) – 2000 mg/kg (Step No. 1)
Dose (mg/kg) (Step No.) | Animal No. | Body weight (g) | Body weight decrease (g) | |||
Before | 2 days | 15 days | 1-2 days | 8-15 days | ||
2000 (1) | 1 | 129.78 | 113.44 | - | 16.34 | - |
2 | 121.76 | 110.00 | - | 11.76 | - | |
3 | 123.99 | 117.33 | - | 6.66 | - | |
mean | 125.18 | 113.59 | - | 11.59 | - | |
SD | 4.14 | 2.43 | - | 4.84 | - |
Table No. 2: Individual body weight (g) – 300 mg/kg (Steps No. 2 and No. 3)
Dose (mg/kg) (Step No.) | Animal No. | Body weight (g) | Body weight gain (g) | |||
Before | 8 days | 15 days | 1-8 days | 8-15 days | ||
300 (2) | 4 | 136.62 | 167.91 | 189.85 | 31.29 | 21.94 |
5 | 125.68 | 151.94 | 166.07 | 26.26 | 14.13 | |
6 | 135.96 | 161.27 | 176.30 | 25.31 | 15.03 | |
mean | 132.75 | 160.37 | 177.41 | 27.62 | 17.03 | |
SD | 6.14 | 8.02 | 11.93 | 3.21 | 4.27 | |
300 (3) | 7 | 129.08 | 158.97 | 190.80 | 29.89 | 31.83 |
8 | 117.64 | 153.47 | 173.94 | 35.83 | 20.47 | |
9 | 112.76 | 138.62 | 154.75 | 25.86 | 16.13 | |
mean | 119.83 | 150.35 | 173.16 | 30.53 | 22.81 | |
SD | 8.38 | 10.53 | 18.04 | 5.02 | 8.11 |
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The test substance toxicity was evaluated on the basis of mortality, clinical signs of intoxication, body weight decrease or increment during the observation period and necropsy findings at the end of study. The test substance administered at the dose 2000 mg/kg caused death of two females and moribund status of one female. The serious clinical signs of intoxication were detected during the study in all three animals administered at the dose 2000 mg/kg.The test substance administered at the lower dose of 300 mg/kg caused no death of females. No clinical signs of intoxication and no macroscopic changes in two administered groups of three females were recorded. According to the study results the value of LD50 of the test substance, Akardit, for female rats is in the range > 300 mg/kg to < 2000 mg/kg.
- Executive summary:
The aim of the study was to investigate acute toxic effects of the test substance Akardit,after a single oral administration to Wistar rats.
The testing was performed according to the Method B.1 tris: Acute Oral Toxicity - Acute Toxic Class Method, Council Regulation (EC) No.440/2008, published in O.J. L 142, 2008.
The test substance was administered in a single dose as solution in vehicle (olive oil), given orally via gavage to female Wistar rats.
The dosing was performed sequentially in three groups of three females: group No. 1 (first step) using the starting dose of 2000 mg/kg body weight, group No. 2 (second step) and group No. 3 (third step) using a dose of 300 mg/kg body weight. The volume of administered solution was 1 ml/100 g body weight of animals.
The test substance administered at the dose of 2000 mg/kg caused death of two females. Remaining one female had to be humanely sacrificed for moribund status in the morning 2ndday of the study.
The clinical signs of intoxication such as piloerection, gibbous posture, decreased reaction to stimuli and tachypnoea were observed immediately 30 minutes after application in all three animals. The lateral posture, ataxia (pulling body and pelvic legs), red discharge from nostrils and salivation appeared 3hours after application in all three females. The piloerection, tachypnoe and decreased reaction to stimuli were still persist.
Two females was found out dead the 2ndday morning after application. At this time the clinical examination was performed only in one moribund female. The clinical signs of intoxication such ascyanotic skin and mucous membrane, lacrimation and salivation, red discharge from nostrils,fur stained by urine was observed in one moribund female and the symptoms of approaching deathsuch as tremor, apathy, ataxia (pulling body and pelvic legs), no reaction to stimuli were observed.
During pathological examination the cachexy, fur stained by urine, cyanosis of skin and mucous membrane, haemorrhagic discharge from nostrils and eye, were found out in all three females. In abdominal cavity the dilatation and flatulence of stomach was recorded in all three females.
The test substance administered at the dose of 300 mg/kg caused no death and no clinical signs in two administered groups of females.
No macroscopic changes were diagnosed during pathological examination.
According to the study results the value of LD50of the test substance, Akardit,for female rats is in the range > 300 mg/kg to < 2000 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.